ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2015 American Transplant Congress

    Validation of the Early Postoperative labMELD as Predictor of Outcome After Transplantation of Extended Criteria Donor Livers

    D. Hoyer,1 A. Gallinat,1 T. Minor,2 F. Saner,1 P. Kocabayoglu,1 J. Treckmann,1 A. Paul.1

    1General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany; 2Surgical Research Division, University Hospital Bonn, Bonn, Germany.

    Background:Since there is no generally accepted standard definition of early allograft dysfunction (EAD) after liver transplantation, we recently suggested postoperative labMELD as predictor for outcome…
  • 2015 American Transplant Congress

    Outcomes of Living and Deceased Donor Liver Transplant Recipients According to the MELD Score

    J. Lee, J. Lee, D. Joo, D. Han, M. Ju, J. Choi, S. Kim, M. Kim.

    Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.

    BackgroundLiving donor liver transplantation (LDLT) has developed as an alternative to decease donor liver transplantation (DDLT) to overcome the critical shortage of deceased organ donations.…
  • 2015 American Transplant Congress

    Pilot Study on Safety and Feasibility of Complete Meal Replacement in Liver Transplant Recipients and Potential Donors

    F. Bhatti,1 M. Jesse,3 K. George,2 J. Centala,4 J. Ehrman,5 A. Eshelman,3 M. Abouljoud,3 K. Brown.

    1Gastroenterology & Hepatology, Henry Ford Health System, Detroit, MI; 2Internal Medicine, Henry Ford Health System, Detroit, MI; 3Transplant Institute, Henry Ford Health System, Detroit, MI; 4Wayne State University, Detroit, MI; 5Cardiology, Henry Ford Health System, Detroit, MI.

    Background: Metabolic syndrome (MS) and hepatic steatosis (HS) are potential long-term complications after liver transplantation (LT). Post-LT caloric intake normalizes which can result in obesity.…
  • 2015 American Transplant Congress

    Outcomes of Patients With Hepatocellular Carcinoma Receiving a Donation After Cardiac Death Liver Graft

    W. Goldkamp,1 J. Vanatta,2,3 S. Nair,2,3 E. Wong,3 N. Dbouk.2,3

    1Internal Medicine, The Universty of Tennessee Health Science Center, Memphis, TN; 2Surgery, The Universty of Tennessee Health Science Center, Memphis, TN; 3Methodist Universty Hospital Transplant Institute, Memphis, TN.

    Background: Recent data suggests that patients with Hepatocellular carcinoma (HCC) who receive a donation after cardiac death (DCD) graft have inferior graft and patient survival…
  • 2015 American Transplant Congress

    Arterial Blood Pressure at Time of Liver Transplant (LT) Evaluation Correlates With Kidney Biopsy Findings in LT Candidates With Renal Dysfunction

    H. Wadei, A. Peguero, A. Alsaad, M. Mai, K. Oshel, T. Gonwa, C. Taner, A. Keaveny.

    Transplant, Mayo Clinic, Jacksonville, FL.

    Renal dysfunction is common in LT candidates; however, predicting post-LT renal recovery is sometimes difficult. Kidney biopsy is helpful in identifying reversible renal injury but…
  • 2015 American Transplant Congress

    The Significant Association Between the Functional Polymorphism (Rs3761548) of Foxp3 Gene and the Severity of Acute Cellular Rejection in Liver Transplantation

    S. Verma, Y. Tanaka, S. Shimizu, L. Das, H. Ohdan.

    Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.

    Aim- Acute cellular rejection (ACR) accounts for 15-25% of graft failure in living donor liver transplantation (LDLT). T regulatory cells (Treg) play an important role…
  • 2015 American Transplant Congress

    Predictors of Time to Recurrence and Mortality Associated With Recurrent Hepatocellular Carcinoma After Liver Transplantation

    A. Bodzin, D. Reino, K. Lunsford, M. Harlander-Locke, D. Markovich, A. Zarrinpar, F. Kaldas, D. Farmer, R. Busuttil, V. Agopian.

    Transplantation, UCLA, Los Angeles, CA.

    Background: While recurrent hepatocellular carcinoma (HCC) after liver transplantation (LT) portends a poor prognosis, adjuvant therapy may prolong survival. We sought to identify factors that…
  • 2015 American Transplant Congress

    Geographic Variation in Listing Practices Represents Competetive Behaviors and Access to Care Rather Than Differences in Demand for Liver Transplantation

    J. Voss,1 R. Gilroy,1 D. Goldberg,2 T. Schmitt,1 S. Kumer.1

    1University of Kansas Medical Center, Kansas City, KS; 2University of Pennsylvania, Philadelphia, PA.

    Purpose: This study evaluates whether program and patient demographics influence liver transplant listing practices.Methods:2013 liver waiting list and transplant (Tx) variables, US Census socioeconomic variables,…
  • 2015 American Transplant Congress

    Sofosbuvir-Based Therapy for Hepatitis C Recurrence Post Liver Transplantation

    A. Ajlan,1 A. Aljedai,1 H. Elsiesy,2 D. Alkortas,1 R. Alarieh,2 F. Aba Alkhail.2

    1Pharmaceutical Care Division, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; 2Liver And Small Bowel Trans and Hep/Pancreatic Surgey -Organ Transplant Centre (OTC), King Faisal Specialist Hospital and Research Centre, Riaydh, Saudi Arabia.

    Introduction:Sofosbuvir is approved to treat HCV infection in all genotypes with sustained virological response 12 weeks after completion of therapy (SVR12)rates of up to 100%.…
  • 2015 American Transplant Congress

    Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Multivariate Analysis of Risk Factors

    M. Elfeki, P. Genco, S. Pungpapong, J. Nguyen, D. Harnois.

    Transplantation, Mayo Clinic, Jacksonville, FL; Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL.

    Introduction:Acute graft versus host disease (GVHD) is a rare fatal complication following orthotopic liver transplantation (OLT). It involves activation of donor T lymphocytes by antigen…
  • « Previous Page
  • 1
  • …
  • 172
  • 173
  • 174
  • 175
  • 176
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences